Zu den Inhalten springen

Spitzenmedizin mit Herz

Hauptnavigation:

The 10 most important publications

1.       Mauler M, Herr N, Schoenichen C, Witsch T, Marchini T, Härdtner C, Koentges C, Kienle K, Ollivier V, Schell M, Dorner L, Wippel C, Stallmann D, Normann C, Bugger H, Walther P, Wolf D, Ahrens I, Lämmermann T, Ho-Tin-Noe B, Ley K, Bode C, Hilgendorf I*, Duerschmied D*.
Platelet serotonin aggravates myocardial ischemia/reperfusion injury via neutrophil degranulation.
Circulation 2019 Feb 12;139(7):918-931

2.       Mauler M*, Seyfert J*, Haenel D, Seeba H, Guenther J, Stallmann D, Schoenichen C, Hilgendorf I, Bode C, Ahrens I*, Duerschmied D*.
Platelet-neutrophil complex formation-a detailed in vitro analysis of murine and human blood samples. Journal of Leukocyte Biology 2016 May;99(5):781-9

3.       von Elverfeldt D*, Maier A*, Duerschmied D*, Braig M, Witsch T, Wang X, Mauler M, Neudorfer I, Menza M, Idzko M, Zirlik A, Heidt T, Bronsert P, Bode C, Peter K*, von Zur Muhlen C*.
Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by MRI.
Circulation 2014 Aug 19;130(8):676-87

4.       Guenther F*, Herr N*, Mauler M, Witsch T, Roming F, Hein L, Boeynaems JM, Robaye B, Idzko M, Bode C, Von Zur Muhlen C, Duerschmied D.
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition.
Journal of Thrombosis and Haemostasis 2013 Jun;11(6):1154-62

5.       Dürk T*, Duerschmied D*, Müller T, Grimm M, Reuter S, Paula Vieira R, Ayata K, Cicko S, Sorichter S, Walther DJ, Virchow JC, Taube C, Idzko M.
Production of serotonin by tryptophan hydroxylase 1 and release via platelets are required for allergic airway inflammation.
American Journal of Respiratory and Critical Care Medicine 2013 Mar 1;187(5):476-85

6.       Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, Mauler M, Cicko S, Bader M, Idzko M, Bode C, Wagner DD.
Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice.
Blood
2013 Feb 7;121(6):1008-15

7.       Duerschmied D*, Meissner M*, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von zur Muhlen C.
Molecular Magnetic Resonance Imaging Allows the Detection of Activated Platelets in a New Mouse Model of Coronary Artery Thrombosis.
Investigative Radiology
2011 Oct;46(10):618-23

8.       Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD.
Extracellular DNA traps promote thrombosis.
Proceedings of the National Academy of Sciences of the United States of America 2010 Sep 7;107(36):15880-5

9.       Duerschmied D*, Canault M*, Lievens D, Brill A, Cifuni S, Bader M, Wagner D.
Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17).
Journal of Thrombosis and Haemostasis 2009 Jul;7(7):1163-71

10.    Duerschmied D, Olson L, Rossknecht A, Freund G, Bode C, Hehrlein C.
Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease - a novel diagnostic method.
European Heart Journal 2006 Feb;27(3):310-5

 

Publications (complete list)

1.       Rilinger J, Staudacher DL, Rieg S, Duerschmied D, Bode C, Wengenmayer T.
Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients. Critical Care. 2019 Nov 14;23(1):356

2.       Schäflein N, Wengenmayer T, Bode C, Busch HJ, Staudacher D, Duerschmied D.
ß-Blocker-Intoxikation – auch im Zeitalter von ECMO eine echte Herausforderung für die Notfall- und Intensivmedizin / ß-blocker poisoning - even in the era of ECMO a real challenge for Emergency- and Intensive Care Medicine. Der Notarzt 2019 Nov

3.       Kaur G, Stallmann D, Schanze N, Laumann R, Heger L, Steinfurt J, Stachon P, Peter K, Boe C, Moser M, Ahrens I, Duerschmied D, Hortmann M.
Extracellular HtrA2 induces apoptosis in human umbilical vein endothelial cells. International Journal of Molecular Sciences. 2019 Oct 31;20(21). pii: E5446.

4.       Dias JD, Pottgiesser T, Hartmann J, Duerschmied D, Bode C, Achneck HE.
Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition. Journal of Thrombosis and Thrombolysis. 2019 Oct 16. doi: 10.1007/s11239-019-01971-1

5.       Heger L*, Hortmann M*, Albrecht M, Colberg C, Peter K, Witsch T, Stallmann D, Zirlik A, Bode C, Duerschmied D, Ahrens I.
Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACS. PLoS One. 2019 Oct 23;14(10):e0224181.

6.       Scretti M, Seeba H, Staudacher D, Robinson S, Stallmann D, Heger L, Grundmann S, Duerschmied D, Bode C, Wengenmayer T, Ahrens I, Hortmann M.
Influence of extracorporeal membrane oxygenation on serum microRNA expression.
Journal of International Medical Research. 2019 Oct

7.       Zotzmann V, Rilinger J, Lang CN, Kaier K, Benk C, Duerschmied D, Biever PM, Bode C, Wengenmayer T, Staudacher DL.
Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience. Critical Care. 2019 Sep 18;23(1):320

8.       Udi J, Köhler TC, Grohmann J, Bäuml M, Grundmann S, Bode C, Biever P, Duerschmied D.
A challenging case of severe pulmonary bleeding in a patient with congenital ventricular septal defect (VSD) and Eisenmenger syndrome: extracorporeal membrane oxygenation (ECMO) support and weaning strategies. Clinical Research in Cardiology. 2019 Sep. doi:10.1007/s00392-019-01544-5

9.       Heger L, Siegel PM, Schwab T, Hortmann M, Stallmann D, Bode C, Duerschmied D.
Zwei Fälle mit früher Stentthrombose nach Myokardinfarkt [Two deleterious cases of early stent thrombosis after myocardial infarction]. Der Kardiologe 2019 Sep, in press

10.    Schoeb DS, Wullich B, Dürschmied D, Heimbach B, Heupel-Reuter M, Gross AJ, Wilhelm K, Gratzke C, Miernik A.
Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines]. Urologe A 2019 Sep;58(9):1029-1038

11.       Grosdidier C, Blanz KD, Deharo P, Bernot D, Poggi M, Bastelica D, Wolf D, Duerschmied D, Grino M, Cuisset T, Alessi MC, Canault M.
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome. Research and Practice in Thrombosis and Haemostasis. 2019 Jul 26;3(4):684-694.

12.       Bode C, Olivier CB, Duerschmied D.
Anticoagulation and anemia – old opponents from the era of VKA?
European Heart Journal. 2019 Aug.0:1-2. pii: ehz628. doi: 10.1093/eurheartj/ehz628

13.       Mauler M, Hilgendorf I, Duerschmied D. Response by Mauler et al to Letter Regarding Article, "Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation”. Circulation 2019 Aug 13;140(7):e292-e293

14.       Bäuml M, Udi J, Klingel K, Bode C, Warnatz K, Zirlik A, Duerschmied D, Biever P.
Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count. Clinical Research in Cardiology. 2019 Aug;108(8):963-966.

15.       Bode C, Olivier CB, Duerschmied D.
Bad boy bleeding – is bleeding always bad?
Journal of the American College of Cardiology. 2019 Sep 24;74(12):1529-1531.

16.       Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV.
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Clinical Research in Cardiology. 2019 Jul;108(7):772-778.

17.       Lother A, Benk C, Staudacher DL, Supady A, Bode C, Wengenmayer T, Duerschmied D.
Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support.
Frontiers in Cardiovascular Medicine. 2019 Jun 4;6:71:1-6.

18.       Tautz E, Wagner D, Wiesemann S, Jonaszik A, Bode C, Wengenmayer T, Staudacher D, Biever P, Hoeppner J, Duerschmied D. Treatment of a broncho-esophageal fistula complicated by severe ARDS. Infection. 2019 Jun;47(3):483-487.

19.       Wengenmayer T, Duerschmied D, Graf E, Chiabudini M, Benk C, Mühlschlegel S, Philipp A, Lubnow M, Bode C, Staudacher DL. Development and validation of a prognostic model for survival in patients treated with venoarterial extracorporeal membrane oxygenation: the PREDICT VA-ECMO score. European Heart Journal: Acute Cardiovascular Care. 2019 Jun;8(4):350-359.

20.    Schanze N, Bode C, Duerschmied D.
Platelet Contributions to Myocardial Ischemia/Reperfusion Injury.
Frontiers in Immunology. 2019 Jun 6;10:1260:1-9.

21.       Gauchel N, Bode C, Duerschmied D.
New aspects of thrombolysis and thrombectomy in pulmonary embolism.
Herz. 2019 Jun;44(4):324-329.

22.       Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators.
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
European Heart Journal. 2019 May 23. pii: ehz367. doi: 10.1093/eurheartj/ehz367

23.       Bemtgen X, Schroth F, Wengenmayer T, Biever PM, Duerschmied D, Benk C, Bode C, Staudacher DL. How to treat combined respiratory and metabolic acidosis after extracorporeal cardiopulmonary resuscitation? Critical Care. 2019 May 21;23(1):183.

24.       Al Said S, Bode C, Duerschmied D. Perspektive nach der COMPASS-Studie für KHK- und AVK-Patienten: Die neue Rolle der oralen Antikoagulationstherapie bei atherosklerotischer Erkrankung.
Der Klinikarzt 2019 Mar;48(3):73-77

25.       Heger LA, Kerber M, Hortmann M, Robinson S, Mauler M, Stallmann D, Duerschmied D, Bode C, Hehrlein C, Ahrens I.
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome. Acta Pharmacologica Sinica 2019 Apr;40(4):500-506.

26.       Mauler M, Herr N, Schoenichen C, Witsch T, Marchini T, Härdtner C, Koentges C, Kienle K, Ollivier V, Schell M, Dorner L, Wippel C, Stallmann D, Normann C, Bugger H, Walther P, Wolf D, Ahrens I, Lämmermann T, Ho-Tin-Noe B, Ley K, Bode C, Hilgendorf I*, Duerschmied D*.
Platelet serotonin aggravates myocardial ischemia/reperfusion injury via neutrophil degranulation. Circulation 2019 Feb 12;139(7):918-931.

27.       Gibson M, Kerneis M, Yee MK, Daaboul Y, Korjian S, Mehr AP, Tricocci P, Alexander JH, Kastelein JJP, Mehran R, Bode C, Lewis BS, Mehta R, Duffy D, Feaster J, Halabi M, Angiolillo DJ, Duerschmied D, Ophius TO, Merkely B.
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
American Heart Journal 2019 Feb;208:81-90.

28.       Hortmann M, Walter JE, Benning L, Follo M, Mayr RM, Honegger U, Robinson S, Stallmann D, Duerschmied D, Twerenbold R, Badertscher P, du Fay de Lavallaz J, Puelacher C, Bode C, Ahrens I, Mueller C. Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. International Journal of Cardiology 2019 Jan 15;275:129-135.

29.       Schoenichen C, Bode C, Duerschmied D.
Role of platelet serotonin in innate immune cell recruitment.
Frontiers in Bioscience (Landmark Ed) 2019 Jan 1;24:514-526

30.    Barber AE, Weber M, Kaerger K, Linde J, Gölz H, Duerschmied D, Markert A, Guthke R, Walther G, Kurzai O.
Comparative genomics of serial Candida glabrata isolates and the rapid acquisition of echinocandin resistance during therapy.
Antimicrobial Agents and Chemotherapy. 2019 Jan 29;63(2).

31.       Duerschmied D. Proceedings of the Third Freiburg Thrombosis Meeting. Hamostaseologie. 2018 Nov;38(4):183-185.

32.       Wengenmayer T, Schroth F, Biever PM, Duerschmied D, Benk C, Trummer G, Kaier K, Bode C, Staudacher DL. Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy is associated with improved survival. Intensive Care Medicine. 2018 Dec;44(12):2312-2314

33.       Al Said S, Bode C, Duerschmied D. Anticoagulation in Atherosclerotic Disease.
Hamostaseologie Nov;38(4):240-246

34.       AlSaid S, Geisen U, Bode C, Dürschmied D.
NOAKs bei Patienten mit KHK: Wann ist eine Gerinnungsanalytik sinnvoll?
Kardiologie up2date. 2018 Aug;14(3):239–249

35.       Duerschmied D, Bode C.
Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention. Thrombosis and Haemostasis 2018 Aug;118(8):1350-1351

36.       Benning L, Robinson S, Follo M, Heger LA, Stallmann D, Duerschmied D, Bode C, Ahrens I, Hortmann M. Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease.
Journal of Visualized Experiments 2018 Jul 3;(137):1-5

37.       Mammadova-Bach E, Mauler M, Braun A, Duerschmied D.
Autocrine and paracrine regulatory functions of platelet serotonin. Platelets. 2018 Sep;29(6):541-548

38.       Sauter RJ, Sauter M, Reis ES, Emschermann FN, Nording H, Ebenhöch S, Kraft P, Münzer P, Mauler M, Rheinlaender J, Madlung J, Edlich F, Schäffer TE, Meuth SG, Duerschmied D, Geisler T, Borst O, Gawaz M, Kleinschnitz C, Lambris JD, Langer HF.
A functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis.
Circulation 2018 Oct 16;138(16):1720-1735

39.       Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schäfer A, Thiele H, Bode C, Zeymer U. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention - should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Clinical Research in Cardiology 2018 Jul;107(7):533-538

40.    Robinson S, Follo M, Haenel D, Mauler M, Stallmann D, Helbing T, Duerschmied D, Peter K, Bode C, Ahrens I, Hortmann M. Chip-based Digital PCR as a Novel Detection Method for Quantifying microRNAs in Acute Myocardial Infarction. Acta Pharmacologica Sinica 2018 Jul;39(7):1217-1227

41.       Dürschmied D, Bode C. Perspektiven der Atherothrombosetherapie nach der COMPASS-Studie – Gibt es bald einen neuen Therapiestandard für Hochrisikopatienten? Der Klinikarzt. 2018 Apr; 47:41-44

42.       Robinson S, Follo M, Haenel D, Mauler M, Stallmann D, Tewari M, Duerschmied D, Peter K, Bode C, Ahrens I*, Hortmann M*. Droplet Digital PCR as a Novel Detection Method for Quantifying microRNAs in Acute Myocardial Infarction. International Journal of Cardiology 2018 Apr 15;257:247-254

43.       Duerschmied D, Bode C. Antikoagulation und Plättchenhemmung nach Koronarintervention. Kompendium Herz-Kreislauf 2018 März; 14:21-24

44.       Staudacher DL, Hamilton SK, Duerschmied D, Biever PM, Zehender M, Bode C, Wengenmayer T. Isoflurane or propofol sedation in patients with targeted temperature management after cardiopulmonary resuscitation: A single center study. Journal of Critical Care 2018 Feb 2;45:40-44

45.       Wolf D, Anto-Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann JD, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc D, Hilgendorf I, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von zur Muhlen C, Reinöhl J, Gerhardt T, Plow E, Yakubenko V, Libby P, Bode C, Ley K, Peter K, Zirlik A. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nature Communications 2018 Feb 6;9(1)525:1-11

46.       Supady A, Duerschmied D, Bode C, Staudacher D. Means for Transport in Patients after Remote Extracorporeal Membrane Oxygenation Implantation. Air Medical Journal 2018 Jan - Feb;37(1):5

47.       Klok FA, Ageno W, Barco S, Binder H, Brenner B, Duerschmied D, Empen K, Faggiano P, Ficker JH, Galiè N, Ghuysen A, Held M, Heydenreich N, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Münzel T, Petris A, Pruszczyk P, Quitzau K, Schellong S, Schmidt KH, Stefanovic BS, Verschuren F, Wolf-Puetz A, Meyer G, Konstantinides SV; PEITHO-2 Investigators. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study. Thrombosis and Haemostasis 2017 Dec;117(12):2425-2434

48.       Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Laumann R, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I. Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury. International Journal of Cardiology 2017 Dec 15;249:437

49.       Staudacher DL, Biever PM, Dürschmied D, Wengenmayer T, Bode C, Ahrens I.
Passagere Herzunterstützungssysteme.
Der Kardiologe 2017 Aug, 5, DOI: 10.1007/s12181-017-0190-9

50.    Herr N, Bode C, Duerschmied D. The Effects of Serotonin in Immune Cells.
Frontiers in Cardiovascular Medicine 2017 July 20;4:48

51.       Duerschmied D, Massberg S. "Platelets as regulators of thrombosis and inflammation”, in the book Platelets, Haemostasis and Inflammation. 2017 ISBN Editors: Zirlik A, Bode C, Gawaz M, Springer, Germany. Book chapter.

52.       Wengenmayer T, Rombach S, Ramshorn F, Biever P, Bode C, Duerschmied D, Staudacher DL. Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR). Critical Care 2017 Jun 22;21(1):157.

53.       Herr N, Dürschmied D. Lungenembolie – aktuelle Therapie und ihre Wirkung im Freiburger Register. UHZ Aktuell 2017 Jul;19:6-7

54.       Klenze H, Köhler TC, Farquharson F, Walterspacher S, Duerschmied D, Roecker K, Kabitz HJ, Walker DJ. Resting limb muscle perfusion during inspiratory muscle loading in hypoxia and normoxia. Respiratory Physiology & Neurobiology 2017 Jun 15;244:1-9

55.       Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I. Circulating HtrA2 as a Novel Biomarker for Mitochondrial Induced Cardiomyocyte Apoptosis and Ischemia- Reperfusion Injury in ST-Segment Elevation Myocardial Infarction. International Journal of Cardiology 2017, Sep 15;243:485-491

56.       Hortmann M, Robinson S, Mohr M, Mauler M, Stallmann D, Reinöhl J, Duerschmied D, Peter K, Carr J, Gibson CM, Bode C, Ahrens I. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction. European Heart Journal: Acute Cardiovascular Care. 2017 May 1:2048872617710789. doi: 10.1177/2048872617710789

57.       Mammadova-Bach E, Mauler M, Braun A, Duerschmied D. Immuno-thrombotic effects of platelet serotonin. in the book Serotonin 2017 ISBN 978-953-51-5290-3 Editor: Shad Kaneez F, InTech, Rijeka, Croatia. Book chapter.

58.       Duerschmied D, Bode C. Register und Studien zu den NOAKs sowie klinischer Stellenwert der Antidots. Der Klinikarzt 2017 Apr; 46(03):92-98.

59.       Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. Journal of the American College of Cardiology 2017 Mar 28;69(12):1536-1544

60.    Greil C, Roether F, La Rosée P, Grimbacher B, Duerschmied D*, Warnatz K*. Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient. Journal of Clinical Immunology 2017 Apr;37(3):273-276

61.       Staudacher DL, Biever PM, Dürschmied D, Wengenmayer T, Bode C, Ahrens I.
Passagere Herzunterstützungssysteme. Notfall + Rettungsmedizin 2017 Jan, 20:63-74

62.       von Zepelin LA, Wladarz D, Cornelis VL, Dürschmied D. Gerettet durch Intensivtherapie – wie war das? Strukturierte Nachbeobachtung kritisch kranker Patienten der Intensivstation Heilmeyer II.
UHZ Aktuell 2016 Okt;16:12-13

63.       Duerschmied D, Schäfer A. "Cath lab after and or during cardiopulmonary resuscitation" - Stellenwert der Herzkatheter-Untersuchung beim reanimierten Patienten.
Herzmedizin 2016 Jul;4:33-39.

64.       Schmidt K, Pottgießer T, Meckel S, Dürschmied D, Bode C, Reinöhl J. "Transcatheter aortic valve implantation and internal carotid artery stenting in a 74-year-old female patient".
Internist (Berl). 2016 Dec;57(12):1235-1242

65.       Marchini T, Wolf D, Michel NA, Mauler M, Dufner B, Hoppe N, Beckert J, Jäckel M, Magnani N, Duerschmied D, Tasat D, Alvarez S, Reinöhl J, von Zur Muhlen C, Idzko M, Bode C, Hilgendorf I, Evelson P, Zirlik A. Acute exposure to air pollution particulate matter aggravates experimental myocardial infarction in mice by potentiating cytokine secretion from lung macrophages.
Basic Research in Cardiology 2016 Jul;111(4):44

66.       Duerschmied D, Bode C.
Hsp70 preventing thrombosis: benefit without burden? Cardiovascular Research 2016 Jun 1;110(3):291-2

67.       Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, Duerschmied D, Bauersachs R, Empen K, Held M, Schwaiblmair M, Fonseca C, Jiménez D, Becattini C, Quitzau K, Konstantinides S. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial. Thrombosis and Haemostasis 2016 Mar 24;116(1)

68.       Walker DJ, Farquharson F, Klenze H, Walterspacher S, Storz L, Duerschmied D, Roecker K, Kabitz HJ. Diaphragmatic fatigue during inspiratory muscle loading in normoxia and hypoxia.
Respiratory Physiology & Neurobiology 2016 Jun 15;227:1-8

69.       Mauler M*, Seyfert J*, Haenel D, Seeba H, Guenther J, Stallmann D, Schoenichen C, Hilgendorf I, Bode C, Ahrens I*, Duerschmied D*. Platelet-neutrophil complex formation-a detailed in vitro analysis of murine and human blood samples. Journal of Leukocyte Biology 2016 May;99(5):781-9

70.    Mauler M, Bode C, Duerschmied D. Platelet serotonin modulates immune functions. Hämostaseologie 2016;36(1):11-6

71.       Dürschmied D, Ahrens I: “Aktuelle Thrombozytenhemmung – Update antithrombotische Therapie beim akuten Koronarsyndrom“, UHZ Aktuell. 2015 Okt:18-19

72.       Dürschmied D, Heinz J, Siepe M, Bode C: “Lungenembolie auf der Intensivstation – die überarbeitete Leitlinie der ESC”, Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2015; 4: 162-171

73.       Diehl P, Bode C, Duerschmied D: “Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis”, Therapeutics and Clinical Risk Management. 2015 Aug 3;11:1133-8

74.       Herr N, Mauler M, Bode C, Duerschmied D: “Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice”, Journal of Visualized Experiments. 2015 Aug 13;(102)

75.       Ahrens I, Chen YC, Topcic D, Bode M, Haenel D, Hagemeyer CE, Seeba H, Duerschmied D, Bassler N, Jandeleit-Dahm KA, Sweet MJ, Agrotis A, Bobik A, Peter K: “HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi”, Thrombosis and Haemostasis. 2015 Jul 23;114(5).

76.       Dürschmied D, Bode C: “Thrombozytenhemmung auf der Intensivstation”
Intensivmedizin up2date. 2015 Jan;11:45–60.

77.       Dürschmied D, Heinz J, Siepe M, Bode C: “Lungenembolie auf der Intensivstation”
Intensivmedizin up2date. 2015 Jan;11:61–75.

78.       Duerschmied D, Bode C, Ahrens I: “Immune functions of platelets”, Thrombosis and Haemostasis. 2014 Sep 11;112(4):678-691.

79.       von Elverfeldt D*, Maier A*, Duerschmied D*, Braig M, Witsch T, Wang X, Mauler M, Neudorfer I, Menza M, Idzko M, Zirlik A, Heidt T, Bronsert P, Bode C, Peter K*, von Zur Muhlen C*: "Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by MRI”, Circulation. 2014 Aug 19;130(8):676-87.

80.    Duerschmied D, Ahrens I, Bode C: "Akutes Koronarsyndrom - Zukünftiger Stellenwert der Thrombozytenhemmung und der DOAKs? / Acute Coronary Syndrome – Future role of platelet inhibition and DOACs?", Der Klinikarzt. 2014 Apr;43(S1):12–18.

81.       Witsch T, Mauler M, Herr N, Stallmann D, Bode C, Hehrlein C, Duerschmied D: “A novel hollow and perforated flexible wire allows the safe and effective local application of thrombolytic therapy in a mouse model of deep vein thrombosis”, Journal of Thrombosis and Thrombolysis. 2014 May; 37(4):450-4.

82.       Herr N, Mauler M, Witsch T, Stallmann D, Schmitt S, Mezger J, Bode C, Duerschmied D: “Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice”, PLoS One. 2014 Feb 10;9(2):e88316.

83.       Duerschmied D, Nitschmann S, Bode C: “[Prevention of recurrent thromboembolisms : WARFASA (Aspirin for the Prevention of Recurrent Venous Thromboembolism - the Warfarin and Aspirin Study).]”, Internist (Berl). 2013 Nov;54(11):1393-6.

84.       Duerschmied D, Bode C: "Brauchen wir Plättchenhemmer und Antikoagulation nach einem akuten Koronarsyndrom?", Vasomed. 2013 Mai;3:138-141.

85.       Guenther F*, Herr N*, Mauler M, Witsch T, Roming F, Hein L, Boeynaems JM, Robaye B, Idzko M, Bode C, Von Zur Muhlen C, Duerschmied D: "Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition", Journal of Thrombosis and Haemostasis. 2013 Jun;11(6):1154-62.

86.       Duerschmied D, Moser M, Bode C: "Neueste Daten und praktische Erfahrungen mit neuen oralen Antikoagulanzien (NOAK) - Welche Patientenkollektive profitieren besonders? / Newest data and practical experience with new oral anticoagulants (NOAK) - Which patients benefit from these drugs?", Der Klinikarzt. 2013 Apr; 42 (S1): 28–37.

87.       Duerschmied D, Ahrens I: "Thrombozyten und Inflammation", UHZ Aktuell. 2013 Apr:15-16

88.       Suidan GL, Duerschmied D*, Dillon GM*, Vanderhorst V, Hampton TG, Wong SL, Voorhees JR, Wagner DD: "Lack of tryptophan hydroxylase-1 in mice results in gait abnormalities", PLoS One. 2013 Mar;8(3):e59032.

89.       Dürk T*, Duerschmied D*, Müller T, Grimm M, Reuter S, Paula Vieira R, Ayata K, Cicko S, Sorichter S, Walther DJ, Virchow JC, Taube C, Idzko M: "Production of serotonin by tryptophan hydroxylase 1 and release via platelets are required for allergic airway inflammation", American Journal of Respiratory and Critical Care Medicine. 2013 Mar 1;187(5):476-85.

90.    Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, Mauler M, Cicko S, Bader M, Idzko M, Bode C, Wagner DD: "Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice", Blood. 2013 Feb 7;121(6):1008-15.

91.       Duerschmied D, Bode C: "Vorapaxar expands antiplatelet options - Which patients may benefit from thrombin receptor antagonism?", Hämostaseologie. 2012 Jul 10;32(3).

92.       Duerschmied D, Bode C, Moser M: "Which Antiplatelet Therapy for Whom?", Aktuelle Kardiologie. 2012;1:44-48.

93.       Duerschmied D, Ahrens I, Mauler M, Brandt C, Weidner S, Bode C, Moser M: "Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study", PLoS One. 2012 Feb;7(2):e32656.

94.       Siller-Matula JM, Merhi Y, Tanguay JF, Duerschmied D, Wagner DD, McGinness KE, Pendergrast PS, Chung JK, Tian X, Schaub RG, Jilma B: "ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion", Arteriosclerosis, Thrombosis, and Vascular Biology. 2012 Apr;32(4):902-9.

95.       Wolf D, Hohmann JD, Wiedemann A, Bledzka K, Blankenbach H, Marchini T, Gutte K, Zeschky K, Bassler N, Hoppe N, Ortiz Rodriguez A, Herr N, Hilgendorf I, Stachon P, Willecke F, Duerschmied D, von Zur Muhlen C, Soloviev DA, Zhang L, Bode C, Plow EF, Libby P, Peter K, Zirlik A: "Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis--But Does Not Affect Immunity and Thrombosis in Mice", Circulation Research. 2011 Nov 11;109(11):1269-79.

96.       Helbing T, Rothweiler R, Ketterer E, Goetz L, Heinke J, Grundmann S, Duerschmied D, Patterson C, Bode C, Moser M: "BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium", Blood. 2011 Nov 3;118(18):5040-9.

97.       Duerschmied D*, Meissner M*, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von zur Muhlen C: "Molecular Magnetic Resonance Imaging Allows the Detection of Activated Platelets in a New Mouse Model of Coronary Artery Thrombosis", Investigative Radiology. 2011 Oct;46(10):618-23.

98.       Duerschmied D, Bode C, Moser M: "Clopidogrel in Acute Coronary Syndrome - Implications of Recent Study Findings", Expert Reviews - Expert Review of Cardiovascular Therapy. 2010 Sep;8(9):1215-29.

99.       Duerschmied D*, Maletzki P*, Freund G, Olschewski M, Bode C, Hehrlein C: "Success of arterial revascularization determined by contrast ultrasound muscle perfusion imaging", Journal of Vascular Surgery. 2010 Sep 14;52(6):1531-6.

100.    Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD: "Extracellular DNA traps promote thrombosis", Proceedings of the National Academy of Sciences of the United States of America. 2010 Sep 7;107(36):15880-5.

101.    Falet H, Pollitt AY, Begonja AJ, Weber SE, Duerschmied D, Wagner DD, Watson SP, Hartwig JH
"A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function"
, Journal of Experimental Medicine. 2010 Aug 30;207(9):1967-79.

102.    Carbo C, Duerschmied D, Goerge T, Hattori H, Sakai J, Cifuni SM, White GC, Chrzanowska-Wodnicka M, Luo HR, Wagner DD: "Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis", Journal of Leukocyte Biology. 2010 Aug;88(2):313-9.

103.    Canault M, Duerschmied D, Brill A, Stefanini L, Schatzberg D, Cifuni S, Bergmeier W, Wagner D: "p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo", Blood. 2010 Mar;115(9):1835-1842.

104.    Duerschmied D, Bode C: "The role of serotonin in haemostasis - Die Rolle von Serotonin in der Hämostase", Hämostaseologie. 2009 Sep;29(4):356-9.

105.    Duerschmied D*, Canault M*, Lievens D, Brill A, Cifuni S, Bader M, Wagner D: "Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)", Journal of Thrombosis and Haemostasis. 2009 Jul;7(7):1163-71.

106.    Diener J, Lagassé D, Duerschmied D, Merhi Y, Tanguay J, Hutabarat R, Gilbert J, Wagner D, Schaub R: “Inhibition of von Willebrand Factor-mediated Platelet Activation and Thrombosis by Anti-von Willebrand Factor A1-Domain Aptamer ARC1779“, Journal of Thrombosis and Haemostasis. 2009 Jul;7(7):1155-62.

107.    Carbo C, Del Conde I, Duerschmied D: "Petechial bleeding after sunburn in a patient with mild thrombocytopenia", American Journal of Hematology. 2009 Aug;84(8):523.

108.    Ho-Tin-Noé B, Goerge T, Cifuni S, Duerschmied D, Wagner D: “Platelet granule secretion continuously prevents intra-tumor hemorrhage“, Cancer Research. 2008 Aug;68(16):6851-8.

109.    Duerschmied D*, Zhou Q*, Rink E, Harder D, Freund G, Olschewski M, Bode C, Hehrlein C: “Simplified contrast ultrasound accurately reveals muscle perfusion deficits and reflects collateralization in PAD“, Atherosclerosis. 2009 Feb;202(2):505-12.

110.    Duerschmied D*, Maletzki P*, Freund G, Olschewski M, Seufert J, Bode C, Hehrlein C: “Analysis of Muscle Microcirculation in Advanced Diabetes Mellitus by Contrast Enhanced Ultrasound“, Diabetes Research and Clinical Practice. 2008 Jul;81(1):88-92.

111.    Freund G, Dürschmied D, Zhou Q, Richter S, Macharzina R, Haas R, Becherer A, Bode C, Hehrlein C: “Occlusion of iatrogenic pseudoaneurysms with percutaneous ultrasound guided thrombin injection“, Vasa. 2007 May;36(2):96-9.

112.    Rink E, Dürschmied D, Harder D, Rossknecht A, Freund G, Hehrlein C: “Contrast enhanced ultrasound perfusion imaging – eine neue Methode zur sonographischen Perfusionmessung der Extremitätenmuskulatur”, in the book Bildverarbeitung für die Medizin. 2006: 454-458. Editors: Handels H, Ehrhardt J, Horsch A, Meinzer H, Tolxdorff T, Springer-Verlag, Heidelberg, Berlin, Germany. Book chapter.

113.    Duerschmied D, Olson L, Rossknecht A, Freund G, Bode C, Hehrlein C
“Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease - a novel diagnostic method”, European Heart Journal. 2006 Feb;27(3):310-5.

114.    Wagner M, Kunsch S, Duerschmied D, Beil M, Adler G, Mueller F, Gress T
“Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas”
, Gastroenterology. 2003 Jun;124(7):1901-14.

115.    Beil M*, Dürschmied D*, Paschke S, Nolte U, Bruel A, Irinopoulou T
“Spatial distribution patterns of interphase centromeres during retinoic acid induced differentiation of promyelocytic leukemia cells”
, Cytometry A. 2002 Apr;47(4):217-25.

116.    Stagge V, Seufferlein T, Dürschmied D, Menke A, Adler G, Beil M
“Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levels”

Pancreas. 2001 Oct;23(3):236-45.

Prof. Dr. med. Dürschmied

Kontakt

Telefon: +49 761 270-70470
Telefax: +49 761 270-70450